Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.42 |
| ▸ | C1R | P00736 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27845272 | 0.84 | ELANE (0.49) | ELANEALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL12958021 | 0.81 | ELANE (0.50) | ELANEALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL19793344 | 0.78 | KDM4E (0.54) | ALDH1A1KDM4ELMNAMAPTPOLB | |
| SCHEMBL295233 | 0.78 | PTGES (0.56) | ELANEALDH1A1KDM4EMAPTMAOA | |
| SCHEMBL31604207 | 0.78 | PTGES (0.56) | ELANEALDH1A1KDM4EMAPTMAOA | |
| SCHEMBL28923758 | 0.77 | ELANE (0.46) | ELANEALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL9104680 | 0.77 | GRIN2D (0.44) | ALDH1A1KDM4EMAPTMAOAMEN1 | |
| SCHEMBL28325016 | 0.77 | MAOA (0.38) | ELANEALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL14985665 | 0.74 | ELANE (0.47) | ELANEALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL9103336 | 0.74 | HIPK2 (0.42) | ALDH1A1LMNAMAOAANTXR2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428273-B2 | Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20180022998-A1 | LIQUID CRYSTAL COMPOUND HAVING BENZOPYRAN SKELETON, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20180022998-A1 | LIQUID CRYSTAL COMPOUND HAVING BENZOPYRAN SKELETON, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428273-B2 | Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device | PIEZO1, PYCARD, NLRP1 | ELANE 2653/4885ALDH1A1 2282/4885KDM4E 2394/4885 |
| US-20180022998-A1 | LIQUID CRYSTAL COMPOUND HAVING BENZOPYRAN SKELETON, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | PIEZO1, NLRP1, PYCARD | ELANE 2588/4885ALDH1A1 2304/4885KDM4E 2257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.